Tag #Monsanto

Showing 1 to 7 of 7 results

sueddeutsche.de

🌐 85% Global Worthiness

Aug 6, 22:15

Bayer's Q2 Results Improved, but Glyphosate Litigation Adds €1.7 Billion Provision

Bayer reported better-than-expected Q2 results but added €1.7 billion to its provisions for US glyphosate and PCB litigation following an unfavorable court ruling; the Supreme Court's decision on a glyphosate case is pending, impacting future legal costs and strategy.

Bayer's Q2 Results Improved, but Glyphosate Litigation Adds €1.7 Billion Provision

Bayer reported better-than-expected Q2 results but added €1.7 billion to its provisions for US glyphosate and PCB litigation following an unfavorable court ruling; the Supreme Court's decision on a glyphosate case is pending, impacting future legal costs and strategy.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does Bayer's legal strategy regarding glyphosate lawsuits in the US aim to mitigate future risks and costs?

The additional provisions reflect Bayer's ongoing legal battles stemming from the Monsanto acquisition. While a settlement reduced open glyphosate lawsuits to 61,000, the Supreme Court's review of a glyphosate ruling is crucial for Bayer, hoping for a decision by next summer to create legal certainty and prevent future claims. Conflicting appellate court rulings add complexity.

sueddeutsche.de

🌐 75% Global Worthiness

Jul 16, 19:15

Bayer Extends CEO's Contract Amidst Restructuring

Bayer CEO Bill Anderson's contract is extended by three years until March 2028, following a restructuring that has eliminated 11,000 jobs and aims for €2 billion in cost savings by 2026, to address legal challenges stemming from the Monsanto acquisition.

Bayer Extends CEO's Contract Amidst Restructuring

Bayer CEO Bill Anderson's contract is extended by three years until March 2028, following a restructuring that has eliminated 11,000 jobs and aims for €2 billion in cost savings by 2026, to address legal challenges stemming from the Monsanto acquisition.

Progress

44% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What is the significance of Bayer extending CEO Bill Anderson's contract amidst ongoing restructuring and legal challenges?

Bayer CEO Bill Anderson's contract has been extended by three years, until the end of March 2028. This follows his initiation of a turnaround program aimed at reducing costs and streamlining operations, which has already resulted in 11,000 job cuts. The company aims to reduce costs by €2 billion by 2026.

sueddeutsche.de

🌐 85% Global Worthiness

Mar 23, 16:11

Bayer Faces $2.1 Billion Roundup Verdict in Georgia

A Georgia jury ordered Bayer to pay $2.1 billion in a Roundup cancer lawsuit, one of the largest awards in the ongoing litigation involving the weed killer, which Bayer insists is not carcinogenic, despite a 2015 IARC classification and over 60,000 pending cases.

Bayer Faces $2.1 Billion Roundup Verdict in Georgia

A Georgia jury ordered Bayer to pay $2.1 billion in a Roundup cancer lawsuit, one of the largest awards in the ongoing litigation involving the weed killer, which Bayer insists is not carcinogenic, despite a 2015 IARC classification and over 60,000 pending cases.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate financial implications for Bayer following the $2.1 billion jury verdict in the Georgia Roundup lawsuit?

In a significant setback, a Georgia jury ordered Bayer to pay $2.1 billion to a plaintiff who claimed Roundup caused his cancer. Bayer announced an appeal, noting this is among the largest sums awarded in Roundup litigation and that they have already paid roughly $10 billion in legal settlements. Over 60,000 cases remain pending.

forbes.com

🌐 75% Global Worthiness

Jan 8, 01:10

Bayer's Cost-Cutting Fails to Offset Losses

Bayer CEO Bill Anderson's cost-cutting measures, including eliminating 5,500 management positions via a new operating model called Dynamic Shared Ownership (DSO), failed to prevent a $4.1 billion net loss and a 44% market cap decline in 2024, highlighting the complexity of resolving a global corpora...

Bayer's Cost-Cutting Fails to Offset Losses

Bayer CEO Bill Anderson's cost-cutting measures, including eliminating 5,500 management positions via a new operating model called Dynamic Shared Ownership (DSO), failed to prevent a $4.1 billion net loss and a 44% market cap decline in 2024, highlighting the complexity of resolving a global corpora...

Progress

52% Bias Score

ShareSaveArticle

Decent Work and Economic Growth

12345678

Previous 1 of 8 Next

What were the immediate consequences of Bayer's management restructuring and cost-cutting efforts in 2024?

Bayer CEO Bill Anderson implemented a new operating model, Dynamic Shared Ownership (DSO), eliminating 5,500 management positions to cut costs by $540 million by 2024 and $2.16 billion by 2026. Despite initial projections, Bayer reported a $4.1 billion net loss and a 44% market cap decline in 2024, indicating that cost-cutting alone was insufficient to address the company's financial challenges.

sueddeutsche.de

🌐 85% Global Worthiness

Aug 1, 19:16

Bayer Raises Forecast Despite €2.2 Billion in Legal Provisions

Bayer raised its 2025 sales forecast to €46-48 billion and Ebitda to €9.7-10.2 billion, driven by pharmaceutical success, while announcing €1.7 billion in provisions for US glyphosate litigation and €530 million for PCB cases, despite settling thousands of Roundup lawsuits.

Bayer Raises Forecast Despite €2.2 Billion in Legal Provisions

Bayer raised its 2025 sales forecast to €46-48 billion and Ebitda to €9.7-10.2 billion, driven by pharmaceutical success, while announcing €1.7 billion in provisions for US glyphosate litigation and €530 million for PCB cases, despite settling thousands of Roundup lawsuits.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the net impact of Bayer's strong pharmaceutical performance and increased legal provisions on its financial outlook and market valuation?

Bayer raised its full-year sales and earnings forecast due to strong performance in its pharmaceutical division. However, the company announced additional provisions of €1.7 billion for legal disputes in the US, mainly for Roundup, a glyphosate-based herbicide, with the lion's share due to a negative US court ruling. Bayer stock rose 1.5 percent.

zeit.de

🌐 85% Global Worthiness

Apr 5, 01:19

Bayer Appeals Glyphosate Ruling to US Supreme Court

Bayer appealed to the US Supreme Court to resolve conflicting US state rulings on glyphosate lawsuits, focusing on a 2023 Missouri case, seeking to curb the thousands of Monsanto-related claims alleging Roundup caused health problems; Bayer maintains Roundup's safety is scientifically proven and glo...

Bayer Appeals Glyphosate Ruling to US Supreme Court

Bayer appealed to the US Supreme Court to resolve conflicting US state rulings on glyphosate lawsuits, focusing on a 2023 Missouri case, seeking to curb the thousands of Monsanto-related claims alleging Roundup caused health problems; Bayer maintains Roundup's safety is scientifically proven and glo...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key legal arguments Bayer is presenting to the Supreme Court regarding glyphosate lawsuits, and what is the potential immediate impact on the company?

Bayer, a German chemical company, appealed to the US Supreme Court due to conflicting rulings in US states regarding glyphosate-related lawsuits. The appeal focuses on a 2023 Missouri case, seeking a ruling to curb the thousands of lawsuits against its subsidiary, Monsanto, alleging Roundup caused health issues. Bayer emphasizes Roundup's safety, scientifically proven and confirmed by global authorities.

taz.de

🌐 75% Global Worthiness

Mar 12, 22:13

Germany Suspends Monsanto's Roundup Future Pesticide"

Germany suspended the sale and use of the Monsanto glyphosate-based pesticide Roundup Future on Tuesday following an objection by the German Environmental Aid (DUH) due to concerns about its safety and environmental impact; the BVL will review the objection and hear Monsanto's response.

Germany Suspends Monsanto's Roundup Future Pesticide"

Germany suspended the sale and use of the Monsanto glyphosate-based pesticide Roundup Future on Tuesday following an objection by the German Environmental Aid (DUH) due to concerns about its safety and environmental impact; the BVL will review the objection and hear Monsanto's response.

Progress

44% Bias Score

ShareSaveArticle

Life on Land

12345678

Previous 1 of 8 Next

What are the immediate consequences of the BVL's suspension of Roundup Future, and what is its significance for glyphosate use in Germany?

Germany's Federal Office of Consumer Protection and Food Safety (BVL) suspended the sale and use of the Monsanto glyphosate-based pesticide Roundup Future following an objection by the German Environmental Aid (DUH). The DUH argues that glyphosate's safety is insufficiently proven and harms biodiversity. The BVL will now review the DUH's objection, hearing Monsanto's response before making a final decision.",

Showing 1 to 7 of 7 results